News
2011
Agilent Technologies Grows Life Sciences Business with Strategic Acquisitions in Next-Generation Sequencing and Automated Analytical Solutions for Pharma
December 1, 2011 — Santa Clara, CA (USA). Agilent Technologies Signs Acquisition Agreement with BioSystem Development, a Provider of Automated Analytical Solutions for Pharmaceutical Development.Agilent Technologies Inc. (NYSE: A) today announced it is expanding its life sciences business with two strategic acquisitions. Halo Genomics, a provider of innovative technology for the rapidly growing next-generation DNA sequencing market, has now joined Agilent. In addition, Agilent has signed a definitive acquisition agreement with BioSystem Development, a company that creates and manufactures solutions to meet the analytical needs of the life sciences industry. more »
BioSystem Development closes a near $1 Million investment round
July 19, 2011 — Madison, WI (USA). BioSystem Development, creator of the AssayMAP® microchromatography technology, announces the recent closure of a fully-subscribed fundraising round, raising just over 1 million dollars (USD). A total of $750,000 of new equity was raised from individual angel investors and a loan from the Madison Development Corporate Venture Debt Fund contributed $300,000. The proceeds will be used to scale up the company’s manufacturing capabilities, increase the speed to market for new products and support pipeline expansion. more »
BioSystem Development Honored as One of the 2011 “Wisconsin Companies to Watch”
March 23, 2011 — Madison, WI (USA). BioSystem Development (BSD) has been recognized as one of the thirty-three 2011 “Wisconsin Companies to Watch,” an awards program presented by the Wisconsin Entrepreneurs’ Network (WEN) with support from the Wisconsin SBDC Network and the Division of Entrepreneurship and Economic Development (DEED) at the University of Wisconsin-Extension in association with the Edward Lowe Foundation. more »
BioSystem Development Selected as a Top 300 Startup
March 18, 2011 — Madison, WI (USA). BioSystem Development (BSD) has been chosen for inclusion in the 2011 Edition of the fundedIDEAS publication - TOP 300 STARTUPS. TOP 300 STARTUPS winners were selected from a pool of 2,518 companies that secured institutional funding in 2010. more »
Agilent Technologies' AssayMAP Bravo and Cartridges for Protein Purification Provide an Automated Solution for High-Throughput Sample Preparation
January 31, 2011, Santa Clara, CA (USA). Agilent Technologies Inc. (NYSE: A) today announced the launch of the AssayMAP Bravo platform and protein purification cartridges, a fully automated solution for high-throughput protein sample preparation and purification. more »
Overcoming Lab Automation Challenges: Flexibility Is Essential as There Is No Such Thing as One-Size-Fits-All Instrumentation
January 15, 2011 — GEN Vol. 31, No. 2. Read the feature article written by Ellyn Kerr published in Genetic Engineering & Biotechnology News that describes our high-throughput microchromatography technology and the Agilent AssayMAP Bravo, a 96-channel robotic liquid handler. more »
2010
SLAS Names $10,000 Innovation Award Finalists for LabAutomation2011
December 14, 2010 — Chicago, IL (USA). The Association for Laboratory Automation, now officially the Laboratory Automation Section of the Society for Laboratory Automation and Screening (SLAS), announced Scott Fulton of BioSystem Development as one the top ten candidates for its $10,000 Innovation Award at LabAutomation2011 for a presentation titled "A New High Throughput Micro-Chromatography Platform for Quantitative Analytical Protein Sample Prep". more »
BioSystem Development and Agilent Technologies Collaborate to Bring Precision and High-Throughput to AssayMAP® Micro-scale Chromatography
December 8, 2010 — Madison, WI (USA) & Santa Clara, CA (USA). BioSystem Development and Agilent Technologies Inc. (NYSE: A) announced a collaborative agreement to implement BioSystem Development’s patented technology on the established Agilent Bravo automated liquid handling platform. BioSystem Development is a privately held life sciences analytics company and creator of AssayMAP® high-throughput micro-chromatography technology. The combined technologies will produce for the first time true chromatography separations on disposable, 5 µl packed-bed columns in a 96-channel SBS microplate format. more »
BioSystem Development and BAC BV Collaborate to Bring Industry-Leading Purification Ligands to High Throughput Biotherapeutic Process Development
November 3, 2010 — Madison, WI (USA) & NAARDEN, The Netherlands. BioSystem Development, creators of AssayMAP® high-throughput micro-chromatography technology and BAC BV, the leading provider of antibody-based affinity purification technology, announce a collaboration to bring state-of-the-art high affinity ligands to the AssayMAP high-throughput micro-chromatography platform. This collaboration marks an essential objective toward growing a family of high-throughput tools for micro-scale purification and quantification of monoclonal antibodies. more »
BioSystem Development closes a near $1 Million investment round
October 11, 2010 — Madison, WI (USA). BioSystem Development, a privately held life science analytics company, announces a recently completed investment round that raised $978,000 (USD) in funding. The proceeds will be used to expand manufacturing infrastructure and to launch new products into the biopharmaceutical development market. more »
BioSystem Development and ProZyme Join Forces to Revolutionize Glycan Sample Preparation
May 11, 2010 — Madison, WI (USA). BioSystem Development, LLC (BSD) and ProZyme, Inc. announce a partnership to redefine biotherapeutic glycan analysis workflow. The first product from this collaboration combines ProZyme’s proprietary enzymatic N-deglycosylation, labeling and cleanup chemistry with BSD’s AssayMAP® high- throughput micro chromatography platform resulting in a rapid, quantitative N-glycan sample preparation method fully enabled for any scale of automation. more »
2009
BioSystem Development Launches its AssayMAP® MAb Titer Assay for Rapid, High-throughput Antibody Measurement in Bioprocess Samples
December 09, 2009 — Madison, WI (USA). BioSystem Development, LLC., a privately held life science analytics company, announces the release of the AssayMAP MAb Titer Assay for measuring antibody product concentrations (or titers) in bioprocess samples. more »
BioSystem Development closes $1.4 Million investment round
November 23, 2009 — Madison, WI (USA). BioSystem Development, LLC., a privately held life science analytics company, announces a recently completed investment round that raised just over 1.4 million dollars (USD) in funding and capital equipment. These funds will help launch new products, finance near‐term product development and expand manufacturing capabilities to the larger scale required to meet demand. more »
2007
BioSystem Development closes on loan from Madison Development Corporation
February 8, 2007 — Read article by Wisconsin Technology Network
BioSystem Development receives angel investment
January 9, 2007 — Read articles by Milwaukee Journal Sentinel and Wisconsin Technology Network
2005
BioSystem Development receives Technology Assistance Grant from Wisconsin Department of Commerce
April 6, 2005 — Read article by Wisconsin Technology Network
BioSystem Development now qualified under Wisconsin Act 255 for Angel Investment Tax Credits.
March 7, 2005 — Read article by Wisconsin Technology Network
2004
BioSystem Development ties for grand prize in first Wisconsin Governor's Business Plan Contest
June 2, 2004 — Read articles by Wisconsin Technology Network and Milwaukee Journal Sentinel